Health Condition 1: N938- Other specified abnormal uterine and vaginal bleeding
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients fulfilling the diagnostic criteria Patients with age group of 18-40 years of either married and unmarried women will be included Patients with Heamoglobin more than 8gm/dl
Exclusion criteria
Exclusion criteria: Pelvic Inflammatory Disease, Benign and Malignant growth in the uterus Patients with IUCD and patients taking OCP Patients with systemic and endocrine disorders interfering with the present study including HTN, DM, Thyroid Dysfunction, PCOS. Patient with bleeding disorder or Coagulopathy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1.reduction in menstrual bleeding 2.normalisation duration of menstruation and intervals between the menstrual cycles 3.Timepoint: 60 Days | — |
Secondary
| Measure | Time frame |
|---|---|
| 1.Symptomatic relief 2.Improvment in quality of lifeTimepoint: 120 Days | — |
Countries
India
Contacts
Shree Jagadguru Gavisiddheshwara Ayurvedic Medical College & Hospital Koppal Karnataka